Gland Pharma Secures USFDA EIR for Dundigal Facility in Hyderabad

Gland Pharma announced that it has secured the establishment inspection report (EIR) from the US drug regulatory authority for its Dundigal site in Hyderabad, marking the conclusion of the inspection. The US Food and Drug Administration (USFDA)...

Odisha Set to Boost Economy with New Pharmaceutical Manufacturing Hub

Odisha government is preparing to establish a pharmaceutical manufacturing hub, which has the potential to significantly impact job creation and economic development in the state. In preparation for the major investment summit Utkarsh Odisha: Make...

Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal

Iconovo AB, a company specializing in inhalable medications created with unique inhalers and dry powder formulations, has partnered with Lonza, a healthcare development and manufacturing firm, to develop spray-dried formulations of an intranasal...

Newron and Myung In Pharm Partner on Evenamide for Schizophrenia

Newron Pharmaceuticals S.p.A, a biopharmaceutical firm dedicated to creating innovative treatments for disorders of the central and peripheral nervous systems, along with Myung In Pharm Co. Ltd. (Myung In Pharm), the foremost CNS-focused...

Lupin Secures US FDA Nod for Pithampur manufacturing facility

Pharmaceutical firm Lupin Ltd has stated that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Pithampur Unit-1 manufacturing facility, which produces both APIs and...

India's Pharma Industry Targets $130 Billion by 2030 to Lead Healthcare

India's pharmaceutical industry plans to increase its size to over USD 120-130 billion by 2030, leveraging innovation to establish itself as the global healthcare guardian, according to Samir Mehta, president of the Indian Pharmaceutical Alliance...

India's Pharma Industry Set for 19.4% YoY Earnings Growth in Q3 FY25

India's pharmaceutical industry is expected to show strong earnings growth of 19.4% year-over-year for the October-December quarter (Q3 FY25), fueled by solid domestic formulation (DF) sales, specialized US generic launches, and lower raw material...

Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets

The Subject Expert Committee (SEC) operating under the Central Drug Standard Control Organisation (CDSCO) has permitted drug giant Sun Pharma Laboratories to produce and sell Fexuprazan Hydrochloride Tablets 40 mg. Nonetheless, this approval is...

Innovent and Roche Partner to Advance Novel DLL3-Targeted ADC, IBI3009

Innovent Biologics, a top-tier biopharmaceutical firm focused on creating, producing, and marketing high-quality drugs for oncology, cardiovascular and metabolic diseases, autoimmune disorders, ophthalmology, and various other serious illnesses...

Akums Unveils New Sterile Facility for Lyophilised Products and Injectables

Akums Drugs and Pharmaceuticals revealed the launch of a new sterile facility focused on manufacturing lyophilised products and injectables, alongside vials, ampoules, eye and ear drops, and form-fill-seal (FFS) products. Lyophilisation involves...